What a Long Strange Trip It’s Been: FDA’s Recent Enforcement in the Product Promotional Arena (and Where we Might be Headed)

Event Details

Schedule

November 29, 2016

Add To Calendar

Location

Internet

Summary

Much has been written and said by us and others about FDA’s latest setbacks in limiting off-label, and what it perceives to be unlawful, promotion. So, what’s the latest and what might we expect to see in the future? In this one-hour complimentary webinar, Alan Minsk of AGG’s Food and Drug Practice Team, will discuss the following topics:

  • FDA’s Enforcement Against Pre-Approval Promotion
  • The PhRMA/BIO Principles on sharing truthful and non-misleading information
  • FDA’s recent public hearing on off-label communications
  • Non-FDA-related issues to consider with off-label promotion
  • Crystal ball time: Where might we be headed

Credits: This webinar is pending CLE credit by the State Bar of Georgia.

Note: The presentation and audio for this webinar will be streamed through your computer, a dial-in number will not be provided.